Randomized, Double-blind, Placebo-controlled (2: 1), Multicenter Clinical Study (IIB) for the Treatment of Stage Ⅳ Soft Tissue Sarcoma With Recombinant Human Endostatin(Endostar) Combined With Chemotherapy
Latest Information Update: 27 Dec 2019
At a glance
- Drugs Endostatin (Primary) ; Docetaxel; Gemcitabine; Ifosfamide; Pirarubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 23 Dec 2019 Status changed from recruiting to completed.
- 04 Jun 2019 Results assessing chemotherapy combined with antiangiogenesis drugs in stage IV sarcoma patients using data from NCT03121833 and NCT03121846 studies, presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 15 May 2017 Status changed from not yet recruiting to recruiting.